1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Confirmation of high prevalence of BAP1 inactivation in mesothelioma
    Meeting Abstract

    Cercek, A.; Zauderer, M. G.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Nash, G. M.; Hmeljak, J.; Ladanyi, M.; Krug, L. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • SARC 028: A phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas
    Meeting Abstract

    Burgess, M. A.; Crowley, J.; Reinke, D. K.; Riedel, R. F.; George, S.; Movva, S.; Van Tine, B. A.; Davis, L. E.; Schuetze, S.; Hu, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Ethnic disparities in the impact of breast cancer on the workforce: A pilot study
    Meeting Abstract

    Blinder, V. S.; Eberle, C. E.; Patil, S.; Ramirez, J.; McNish, T.; Min, S. H.; Bhagwati, N.; Lee, S.; Hudis, C. A.; Oeffinger, K. C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Racial differences in 20-year cardiovascular outcomes among childhood and young adult cancer survivors
    Meeting Abstract

    Berkman, A. M.; Jones, L.; Crocker, A.; Brewster, A. M.; Lakoski, S. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • KEYNOTE-045: Randomized phase 3 trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel, or vinflunine for previously treated metastatic urothelial cancer
    Meeting Abstract

    Bellmunt, J.; Sonpavde, G.; De Wit, R.; Choueiri, T. K.; Siefker-Radtke, A. O.; Plimack, E. R.; Lewis, N. M.; Brown, H.; Mai, Y. B.; Gause, C. K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
    Meeting Abstract

    Bell-Mcguinn, K. M.; Brady, W. E.; Schilder, R. J.; Fracasso, P. M.; Moore, K. N.; Walker, J. L.; Duska, L. R.; Mathews, C. A.; Chen, A.; Shepherd, S. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Enzalutamide (ENZA) in men with chemotherapy-Naive metastatic castration-resistant prostate cancer (mCRPC): Final analysis of the phase 3 PREVAIL study
    Meeting Abstract

    Beer, T. M.; Armstrong, A. J.; Sternberg, C. N.; Higano, C. S.; Rathkopf, D. E.; Loriot, Y.; Saad, F.; Joshua, A. M.; de Bono, J. S.; Venner, P. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Employment and quality of life (QOL) in human papillomavirus-related (HPV+) oropharynx cancer treated with definitive chemoradiation (CTRT)
    Meeting Abstract

    Baxi, S. S.; Xiao, H.; Fury, M. G.; Atoria, C. L.; Dunn, L.; Salz, T.; Sherman, E. J.; Ho, A. L.; Lee, N. Y.; Pfister, D. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of MEDI6383, an OX40 agonist, in adult patients with select advanced solid tumors
    Meeting Abstract

    Bauer, T. M.; Chae, Y. K.; Patel, S.; D'Angelo, S. P.; Blumenschein, G. R.; Norton, J.; Pound, C.; Lanasa, M. C.; Curti, B. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Using mutational load in next generation sequencing (NGS) to identify mismatch repair (MMR) deficiency in colorectal cancer (CRC)
    Meeting Abstract

    Battaglin, F.; Stadler, Z. K.; Cercek, A.; Yaeger, R. D.; Segal, N. H.; Varghese, A. M.; Kemeny, N. E.; Weiser, M. R.; Garcia-Aguilar, J.; Shia, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save